menu search

ARKG / Why a Biotech ETF Might Cure Your Portfolio in 2023

Why a Biotech ETF Might Cure Your Portfolio in 2023
While the headlines have focused on a crypto winter, it hasn't exactly been an easy year for biotech. The sector that blossomed amid a global pandemic has struggled with the pandemic easing and rates rising. Read More
Posted: Dec 7 2022, 14:52
Author Name: ETF Trends
Views: 111826

ARKG News  

5 ETF Areas That Spooked Investors in October

By Zacks Investment Research
October 30, 2023

5 ETF Areas That Spooked Investors in October

After a downbeat September, October too remained volatile for Wall Street due to higher rates. more_horizontal

Why Wall Street Thinks This Artificial Intelligence (AI) Stock Could Skyrocket 140% Over the Next 12 Months

By The Motley Fool
October 16, 2023

Why Wall Street Thinks This Artificial Intelligence (AI) Stock Could Skyrocket 140% Over the Next 12 Months

This company uses AI to improve drug discovery for all of the 20 biggest biopharmaceutical companies. Even the most pessimistic analyst thinks the sto more_horizontal

Best Healthcare ETFs to Buy Now

By Kiplinger
August 24, 2023

Best Healthcare ETFs to Buy Now

The best healthcare ETFs patch investors into an area of the market that offers both defensive properties and long-term growth. more_horizontal

Cathie Wood Is Buying Up Shares of This Beaten-Down Biotech. Should You?

By The Motley Fool
July 27, 2023

Cathie Wood Is Buying Up Shares of This Beaten-Down Biotech. Should You?

Superstar investor Cathie Wood bought shares of Moderna over a period of two days this week. The biotech company may become a respiratory vaccine gian more_horizontal

ARKG: Smart Idea for Smart Advancements in Cancer Treatment

By ETF Trends
April 24, 2023

ARKG: Smart Idea for Smart Advancements in Cancer Treatment

The cancer treatment/immuno-oncology market is expansive and ripe with potential for long-term healthcare investors. Predictably, there are significan more_horizontal

Biotech ETFs' Performance Deserves A Look

By ETF Trends
April 19, 2023

Biotech ETFs' Performance Deserves A Look

Biotech comes with a great many positive externalities for society, and can be a big positive for portfolios right now. more_horizontal

ARKG: A Probable Window Of Opportunity, Depending On Banks And The Fed

By Seeking Alpha
April 12, 2023

ARKG: A Probable Window Of Opportunity, Depending On Banks And The Fed

Cathie Wood's ARKG provides investors with an opportunity to take advantage of the billion-dollar genomics market. However, it has performed poorly co more_horizontal

Thematic Index Lineup Joins VettaFi and the Future Is Bright

By ETF Trends
April 10, 2023

Thematic Index Lineup Joins VettaFi and the Future Is Bright

A decade ago, when the ROBO Global Robotics & Automation Index ETF (ROBO) launched, the U.S. thematic ETF market was nascent, with only a handful of p more_horizontal


Search within

Pages Search Results: